Appointments

• 2026–presentAssociate Professor, Department of Economics, City St George’s, University of London
• 2022–presentVisiting Professor, Department of Infectious Diseases, Pontificia Universidad Católica de Chile
• 2021–presentHonorary Research Fellow, Institute for Global Health, University College London
• 2024–2026Senior Research Associate, Nuffield Department of Primary Care Health Sciences, University of Oxford
• 2023Research Fellow, Department of Disease Control, London School of Hygiene & Tropical Medicine
• 2022–2023Postgraduate Research Associate, University of Exeter
• 2021Research Analyst, Institute for Global Health, University College London
• 2018–2019Research Analyst, School of Public Health, Columbia University, USA
• 2016–2017Macroeconomic Analyst, JP Morgan Chase, Chile
• 2015Macroeconomic Analyst, Central Bank of Chile

Education

• 2024PhD, Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine
• 2020MSc, Health Economics and Decision Science, University College London (Merit)
• 2016MA, Economic Analysis, Universidad Diego Portales, Chile (Honours)
• 2014BSc, Business Engineering and Economics, Universidad Diego Portales, Chile (Honours)

Postgraduate certificates

• 2023Modern Techniques for Modelling Infectious Disease Dynamics, London School of Hygiene & Tropical Medicine
• 2021Specialisation in Infectious Diseases Modelling, Imperial College London
• 2019Spatial Analysis, London School of Hygiene & Tropical Medicine
• 2014Applied Machine Learning, Columbia University, USA
• 2014Strategic Thinking in Management and Economics, State University of New York, USA

Consultancy

• 2026–presentConsultant, GAIHN-AR, South America. Centers for Disease Control and Prevention, USA
• 2026–presentConsultant, antimicrobial resistance burden among patients with bloodstream infections in Kyrgyzstan. World Health Organization, Switzerland
• 2026–presentAdvisor, health economics of intelligence surveillance. NEX-Intelligence infection surveillance platform, UK
• 2024–2026Consultant, targeting vaccine campaigns using health records from the NHS COVID-19 app. Ministry of Social Care and the Policy Innovation and Evaluation Research Unit, National Institute for Health Research and London School of Hygiene & Tropical Medicine
• 2021Consultant, WHO consolidated guidelines on tuberculosis (2022), Module 3: Diagnosis, tests for tuberculosis infection. World Health Organization
• 2021Consultant, evidence to inform COVID-19 policy and mitigation in Nigeria

Service and leadership

• 2026–presentAcademic Editor, Editorial Board, PLOS Medicine
• 2025–presentSenior Collaborator, Global Burden of Disease programme, Institute for Health Metrics and Evaluation
• 2025–2026Main Editor, special issue Economics of Antimicrobial Resistance, Value in Health Regional Issues
• 2025Member, WHO Europe AMR Accountability Index expert panel
• OngoingJournal referee for The Lancet, Nature Communications, Cell Press, Eurosurveillance, Lancet Public Health, Value in Health and others

Awards and scholarships

• 2024Grand Prize, AMR Surveillance Data Challenge, Vivli and the Wellcome Trust
• 2024Top 2% of scientists globally, Stanford–Elsevier indicators
• 2024Top-ranked scientific poster (ribbon award), bacterial diseases section, ESCMID annual meeting
• 2023Monica Suarez Prize for a young scientist, antimicrobial resistance burden in Chile, Chilean Society of Infectious Diseases (SOCHINF)
• 2023Bridging Salary Scheme, University of Exeter
• 2023People’s Prize for a scientific poster, London School of Hygiene & Tropical Medicine
• 2022–2023Doctoral project travelling award, London School of Hygiene & Tropical Medicine
• 2020–2024Full International PhD Scholarship, ANID, Chile
• 2019–2020Full International Master’s Scholarship, ANID, Chile

Professional societies and networks

• 2026–presentMember, Chilean Society of Infectious Diseases (SOCHINF)
• 2026–presentAffiliate fellow, JUNIPER (Joint Universities Pandemic and Epidemiological Research)
• 2026–presentCollaborator, SENTINET (Center for Surveillance, Epidemiology, and Technologies for Emerging Infectious Threats), Chile
• 2026Selected for the Future Antimicrobial-resistance Network (FAN) Building Leaders Programme for early- and mid-career researchers, UKRI
• 2024–presentMember, European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
• 2021–2024Member, Royal Society of Tropical Medicine and Hygiene (RSTMH)
• 2021–2024Antimicrobial Resistance Centre, London School of Hygiene & Tropical Medicine
• 2021–2023Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine
• 2021Member, Medical Research Foundation National PhD Training Programme in Antimicrobial Resistance Research, UK

Selected publications

• Global antimicrobial-resistance drivers: an ecological country-level study at the human–animal interface Allel K, Day L, Hamilton A, Lin L, Furuya-Kanamori L, et al. Lancet Planetary Health 2023; 7: e291–303
• The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries: a systematic review and meta-analysis Allel K, Stone J, Undurraga EA, Day L, Moore CE, Lin L, Furuya-Kanamori L, Yakob L PLOS Medicine 2023; 20(6): e1004199
• Estimating optimal levels of WHO Access, Watch, Reserve (AWaRe) antibiotic use in 186 countries, territories, and areas Cook A, Cooper B, Thorn M, et al., Allel K, et al., Sharland M Lancet Public Health 2026; 11(8): e476–486
• Trends and drivers of multidrug-resistant bacteria incidence in 59 Chilean intensive care units, 2015–2024: a Bayesian hierarchical analysis Acuña MP, Ross P, Carcamo G, et al., Allel K Lancet Regional Health – Americas 2026; 58: 101467
• Cost-effectiveness of screening, decolonisation and isolation strategies for carbapenem-resistant Enterobacterales and methicillin-resistant Staphylococcus aureus infections in hospitals Allel K, Garcia P, Peters A, Munita J, Undurraga EA, Yakob L Lancet Regional Health – Americas 2025; 43: 101019
• Excess burden of antibiotic-resistant bloodstream infections: evidence from a multicentre retrospective cohort study in Chile, 2018–2022 Allel K, Peters A, Haghparast-Bidgoli H, et al. Lancet Regional Health – Americas 2024; 40: 100943

Funding

Selected grants totalling £9.10 million ($12.05 million), as principal investigator (PI) or co-investigator (Co-I).

• 2026–2031Co-I. Gut microbiome biomarkers and antibiotic-use impact on resistant infectionsWellcome Leap$7,000,000
• 2026–2030Co-I. CHANGES Hub: climate action and health evidence synthesisWellcome Trust£1,500,000
• 2027–2030Co-I. Antibiotic Access Project: estimating antibiotic needsBill & Melinda Gates Foundation£1,400,000
• 2021–2023Co-I. Cost-effectiveness of C. difficile vaccine deployment, UKPfizer Inc.£350,000
• 2023–2024Co-I. Aedes aegypti and Aedes albopictus roles in dengue transmissionMerck Sharp & Dohme£209,000
• 2025–2028Co-I. WinTB: TB window prophylaxis in household contactsFondecyt, Chile£200,000
• 2023–2024Co-I. Modified short treatment for MDR/RR-TB, Eastern Europe and Central AsiaThe Global Fund£50,000
• 2025Co-I. ICU microbiome and hospital-acquired infection prevention, ChileAvanza UC, Pontificia Universidad Católica de Chile£35,000
• 2025PI. Optimising antibiotic use in primary care in South AmericaUniversity of Oxford£12,000
• 2025–2026Co-I. Integration of carbon metrics in healthcareUniversity College London£12,000
• 2025–2026Co-I. Ultra-processed food and the chemistry withinIUPAC$11,750
• 2026–2027Co-I. Advancing bottom-up antimicrobial resistance and use research in Latin AmericaRoyal Society of Edinburgh£10,000
• 2022Co-I. The Guarani-Mbyá study: socio-cultural epidemiology and immunodeficiencyUniversity College London£10,000
• 2019Co-I. Proposal for control and prevention of antimicrobial resistance, ChilePontificia Universidad Católica de Chile$10,000
• 2026–2027PI. Antibiotic prescribing and use in primary care, ChileEPSRC and University College London£7,000
• 2021PI. Burden of antibiotic-resistant bloodstream infections in ChileRoyal Society of Tropical Medicine and Hygiene£5,000

Invited talks

• 2026The strategic value of new antimicrobials in combating resistance: burdens, macroeconomic costs, and LATAM impact. LATAM Antimicrobial Resistance Summit
• 2026Global pricing of key AWaRe antibiotics. EU Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI), Norway
• 2026Cost-effectiveness of the GAIHN-AR intervention: a quasi-experimental approach. Centers for Disease Control and Prevention, Atlanta, USA
• 2025The burden of antimicrobial resistance and potential interventions in South America. Department of Economics, Bocconi University, Italy
• 2025Environmental and geo-economic impact of conservative versus liberal oxygen strategies in mechanically ventilated critically ill patients. SOCHIMI, Chile
• 2025The role of data sharing and re-use: a case study in antimicrobial resistance. National Institutes of Health, USA
• 2025Reusing pharmaceutical data to understand antimicrobial resistance. Antimicrobial Resistance Centre, London School of Hygiene & Tropical Medicine
• 2024The burden of antimicrobial resistance causing bloodstream infections: learning and outcomes. Brown bag seminar series, Institute for Global Health, University College London
• 2024Global impacts of antimicrobial resistance: what about the Chilean context? Chilean Society of Infectious Diseases
• 2024Developing a conceptual framework to improve understanding of antimicrobial resistance in livestock systems: translating research into policy and practice. Workshop in Argentina, invited by UKRI, the Global AMR Innovation Fund, CONICET and the British Embassy in Argentina
• 2021Successful examples of public policies in controlling antimicrobial resistance globally. CURICURB annual university course on antimicrobial resistance, Curicó, Chile

Conference presentations

• 2026International Network for Antimicrobial Resistance Social Science (INAMRSS), 5th edition, Munich, Germany
• 2026ESCMID Global, 36th annual meeting, Munich, Germany
• 2025International Health Economics Association (iHEA), 16th World Congress, Bali, Indonesia
• 2025ESCMID Global, 35th annual meeting, Vienna, Austria
• 2024ISPOR Europe, Barcelona, Spain
• 2024ESCMID Global, 34th annual meeting, Barcelona, Spain. Top-ranked scientific poster (ribbon award), bacterial diseases section
• 2023Australasian Epidemiological Association annual scientific meeting, Melbourne, Australia
• 2023American Society of Tropical Medicine and Hygiene (ASTMH), 71st annual meeting
• 2021International Health Economics Association (iHEA), 14th World Congress
• 2020International Congress on Infectious Diseases (ICID), 19th edition, Kuala Lumpur, Malaysia
• 2018XIX International Sociological Association World Congress, Canada, and Chilean Society of Economists

In the media

Press coverage

• Antibiotic consumption and resistance is a ‘two-way street’ between animals and humans. Coverage of the Lancet Planetary Health study in The Independent, Evening Standard, Daily Mail, Public News Time, The Irish News, n-tv, Yahoo, News-Medical.net and CIDRAP.
• Pneumonia and urinary tract infections in Chile are becoming more resistant to antibiotics. El Mercurio and Pontificia Universidad Católica de Chile, 2023.
• Study reveals increase in mortality and public health costs due to antibiotic resistance. Cooperativa, national radio and newspaper, Chile, 2023.
• Data on Fire: How AI Is Transforming the Healthcare Industry. Forbes Chile, 2025.

Interviews and podcasts

• Antimicrobial Resistance Awareness, fireside interview. Vivli, Loeb House, Harvard University, Boston, USA, 2025.
• Superbugs Everywhere All at Once: the not-so-simple fight to control drug-resistant bacteria. One Health Trust and the Center for Disease Dynamics, Economics & Policy, Washington DC, USA, 2023.

Science communication

• Reflections on the ESCMID Global conference on clinical microbiology and infectious diseases. London School of Hygiene & Tropical Medicine, 2025.

Courses and lectures

• 2025Course lead, Introduction to Health Economics, MSc Modelling for Global Health, University of Oxford
• 2025Invited lecturer, Epidemiology and Health Economics, Pontificia Universidad Católica de Chile
• 2024Course tutor, Economic Evaluation, MSc Modelling for Global Health, University of Oxford
• 2024Course tutor, Control of Infectious Diseases, London School of Hygiene & Tropical Medicine
• 2023Invited guest lecturer, Antimicrobial Resistance: a Multidisciplinary Approach, London School of Hygiene & Tropical Medicine
• 2023Invited lecturer, Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine
• 2023Course tutor, Modelling and Dynamics of Infectious Diseases, London School of Hygiene & Tropical Medicine
• 2022Invited lecturer, Key Principles of Health Economics, University College London

Doctoral supervision

Co-supervisor of five doctoral students.

• 2025–presentMayar Al-Mohajer, DPhil Primary Care, University of Oxford. An equity-centred stewardship pathway for older adults: determinants, appropriateness, outcomes and policy effects in US antibiotic use.
• 2024–presentAyisha Khalid, DPhil Population Health, University of Oxford. Spatio-temporal contribution of candidate factors to the differential global distribution of HIV-1 diversity.
• 2024–presentXin Xu, PhD Epidemiology and Health Statistics, Zhejiang University, China. Effectiveness of educational interventions within the community to improve antibiotic prescribing in China.
• 2023–presentHassanat Lawal, PhD Medical Sciences, University of Exeter. Probiotics for urogenital infection management: knowledge and understanding of patients and the UK’s primary health providers.
• 2023–2026Franco Fernandez, PhD Public Health, Universidad de Chile. Disease burden of Chagas disease in Chile.

Master’s, undergraduate and research supervision

• 2026MSc Global Health Science and Epidemiology, University of Oxford
• 2025MSc Modelling for Global Health, University of Oxford
• 2025National Institute for Health Research pre-doctoral fellowship, University of Oxford
• 2025Visiting scholar training in tuberculosis transmission and economic modelling, University of Oxford
• 2023–2024Research assistant in infectious diseases, London School of Hygiene & Tropical Medicine
• 2023–2024BSc Medical Sciences, University of Exeter
• 2023–2024BSc Human Sciences, University College London
• 2023NIHR School for Primary Care Research programme for undergraduate students
• 2022–2023MPH, London School of Hygiene & Tropical Medicine
• 2021–2022MSc, London School of Economics (two students)
• 2020–2021MSc, London School of Hygiene & Tropical Medicine

External examination

• 2025External Assessor, Institute of Public Health of Chile, Ministry of Science competitive grant agreement
• 2024Examiner, MSc Epidemiology, School of Population Health, University of Queensland
• 2023Examiner, MSc Control of Infectious Diseases, London School of Hygiene & Tropical Medicine